US Stock MarketDetailed Quotes

PRCT PROCEPT BioRobotics

Watchlist
  • 57.030
  • -2.000-3.39%
Close Mar 18 16:00 ET
  • 57.030
  • 0.0000.00%
Post 16:20 ET
3.13BMarket Cap-32.59P/E (TTM)

About PROCEPT BioRobotics Company

PROCEPT BioRobotics Corp. is a commercial-stage surgical robotics company, which engages in the development of transformative solutions in urology. It manufactures and sells the AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery, with an initial focus on treating BPH. The firm's proprietary AquaBeam Robotic System employs a single-use disposable handpiece to deliver its Aquablation therapy, which combines real-time, multidimensional imaging, personalized treatment planning, automated robotics and heat-free waterjet ablation for targeted and rapid removal of prostate tissue. The company was founded by Nikolai Aljuri and Rodney C. Perkins in 2007 and is headquartered in San Jose, CA.

Company Profile

SymbolPRCT
Company NamePROCEPT BioRobotics
Listing DateSep 15, 2021
Issue Price25.00
Founded2007
CEODr. Reza Zadno, PhD
MarketNASDAQ
Employees756
Fiscal Year Ends12-31
Address150 Baytech Drive
CitySan Jose
ProvinceCalifornia
CountryUnited States of America
Zip Code95134
Phone1-650-232-7200

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Reza Zadno, PhD
  • President, Chief Executive Officer and Director
  • 6.09M
  • Kevin M. Waters
  • Executive Vice President, Principal Accounting Officer and Chief Financial Officer
  • 2.67M
  • Hisham Shiblaq
  • Executive Vice President and Chief Commercial Officer
  • 2.63M
  • Alaleh Nouri
  • Executive Vice President, Chief Legal Officer and Corporate Secretary
  • 2.19M
  • Thomas M. Prescott
  • Chairman of the Board
  • --
  • Taylor C. Harris
  • Independent Director
  • 254.92K
  • Mary Garrett
  • Independent Director
  • 244.92K
  • Elisabeth A. Sandoval Little
  • Independent Director
  • 242.16K
  • Amy M. Dodrill
  • Independent Director
  • 252.42K
  • Larry L. Wood
  • Independent Director
  • --
  • Dr. Frederic H. Moll,M.D.
  • Independent Director
  • 277.64K
  • Antal Desai
  • Independent Director
  • 247.42K
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.